![]() | |
![]() | |
Clinical data | |
---|---|
Trade names | Sular, Baymycard, Syscor |
AHFS/Drugs.com | Monograph |
MedlinePlus | a696009 |
Routes of administration | Oral |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | 4–8% |
Protein binding | >99% |
Metabolism | CYP3A4 |
Elimination half-life | 7–12 hours |
Excretion | 70–80% via urine |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.058.534 |
Chemical and physical data | |
Formula | C20H24N2O6 |
Molar mass | 388.420 g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
Nisoldipine is a pharmaceutical drug used for the treatment of chronic angina pectoris and hypertension. It is a calcium channel blocker of the dihydropyridine class. It is sold in the United States under the proprietary name Sular. Nisoldipine has tropism for cardiac blood vessels.[1]
It was patented in 1975 and approved for medical use in 1990.[2]
Contraindications[edit]
Nisoldipine is contraindicated in people with cardiogenic shock, unstable angina, myocardial infarction, and during pregnancy and lactation.[3]
Adverse effects[edit]
Common side effects are headache, confusion, fast heartbeat, and edema. Hypersensitivity reactions are rare and include angioedema.[3]
Interactions[edit]
The substance is metabolized by the liver enzyme CYP3A4. Consequently, CYP3A4 inducers such as rifampicin or carbamazepine could reduce the effectiveness of nisoldipine, while CYP3A4 inhibitors such as ketoconazole increase the amount of nisoldipine in the body more than 20-fold. Grapefruit juice also increases nisoldipine concentrations by inhibiting CYP3A4.[3]
Pharmacology[edit]
Mechanism of action[edit]
Nisoldipine is a calcium channel blocker that selectively inhibits L-type calcium channels.[3]
References[edit]
- ^ Knorr AM (April 1995). "Why is nisoldipine a specific agent in ischemic left ventricular dysfunction?". The American Journal of Cardiology. 75 (13): 36E–40E. doi:10.1016/S0002-9149(99)80446-9. PMID 7726122.
- ^ Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 464. ISBN 9783527607495.
- ^ a b c d Haberfeld H, ed. (2019). Austria-Codex (in German). Vienna: Österreichischer Apothekerverlag. Syscor 5 mg-Filmtabletten.
Further reading[edit]
- Mielcarek J, Grobelny P, Szamburska O (April 2005). "The effect of beta-carotene on the photostability of nisoldipine". Methods and Findings in Experimental and Clinical Pharmacology. 27 (3): 167–171. doi:10.1358/mf.2005.27.3.890873. PMID 15834448.
- Missan S, Zhabyeyev P, Dyachok O, Jones SE, McDonald TF (November 2003). "Block of cardiac delayed-rectifier and inward-rectifier K+ currents by nisoldipine". British Journal of Pharmacology. 140 (5): 863–870. doi:10.1038/sj.bjp.0705518. PMC 1574108. PMID 14530219.
- Hamilton SF, Houle LM, Thadani U (1999). "Rapid-release and coat-core formulations of nisoldipine in treatment of hypertension, angina, and heart failure". Heart Disease. 1 (5): 279–288. PMID 11720635.
External links[edit]
- Diseases Database (DDB): 30009
Well, that’s interesting to know that Psilotum nudum are known as whisk ferns. Psilotum nudum is the commoner species of the two. While the P. flaccidum is a rare species and is found in the tropical islands. Both the species are usually epiphytic in habit and grow upon tree ferns. These species may also be terrestrial and grow in humus or in the crevices of the rocks.
View the detailed Guide of Psilotum nudum: Detailed Study Of Psilotum Nudum (Whisk Fern), Classification, Anatomy, Reproduction